Cargando…
Engendering health systems in response to national rollout of dolutegravir-based regimens among women of childbearing potential: a qualitative study with stakeholders in South Africa and Uganda
BACKGROUND: In the era of rapid dolutegravir rollout, concerns about neural tube defects have complicated the health systems response among women of childbearing potential. This qualitative study, which was nested within the DolPHIN-2 clinical trial, examined the current and future health system opp...
Autores principales: | Alhassan, Yussif, Twimukye, Adelline, Malaba, Thoko, Orrell, Catherine, Myer, Landon, Waitt, Catriona, Lamorde, Mohammed, Kambugu, Andrew, Reynolds, Helen, Khoo, Saye, Taegtmeyer, Miriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395396/ https://www.ncbi.nlm.nih.gov/pubmed/32738918 http://dx.doi.org/10.1186/s12913-020-05580-0 |
Ejemplares similares
-
Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2020) -
“It’s only fatness, it doesn’t kill”: a qualitative study on perceptions of weight gain from use of dolutegravir-based regimens in women living with HIV in Uganda
por: Alhassan, Yussif, et al.
Publicado: (2022) -
‘I fear my partner will abandon me’: the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2022) -
A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy
por: Ochanda, Perez Nicholas, et al.
Publicado: (2022) -
Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study)
por: Waitt, Catriona, et al.
Publicado: (2019)